Technology Transfer Office | University of Colorado

CU Technologies Available for Licensing

Technology Transfer Office of University of Colorado
Browse by Category
Life Science
Physical Science
Technology Transfer Office of University of Colorado
Back to Main Page
     Key Word Search
     View Our Pipelines
     Sign up for Tech Alert
Diagnostic (27)
Tech. Category Tech. ID Technology Summary Available? TTO Contact
Biomarker(Adverse Events and Prognosis) CU2330H MicroRNA-520e Influences Disease-Free and Overall Survival in Non-Small Cell Lung Cancer (NSCLC) No, contact TTO Rick Silva
Biomarker(Adverse Events and Prognosis) CU2428H SASH1 involved in the development of common benign skin lesions called lentigines No, contact TTO David Poticha
Biomarker(Adverse Events and Prognosis) CU3028H FOXA1 as a marker for invasive bladder cancer No, contact TTO Kimberly Muller
Assay and Analytics CU1137B On Chip Signal Amplification by Photopolymerization Yes, download Stephanie Villano
Assay and Analytics CU1384B Detection Of Molecular Recognition Without The Use Of Instrumentation: Photopolymerization Of Macroscopically Thick Films Following A Recognition Event Yes, download Stephanie Villano
Assay and Analytics CU1915B Liquid Crystal Based Detection of Nucleic Acid Hybridization at the Fluid Interface Yes, download Stephanie Villano
Assay and Analytics CU1970B Use of UV Photopolymerization for Amplification and Detection of a Molecular Recognition Event Yes, download Stephanie Villano
Assay and Analytics CU1972B Use of Visible Light Photopolymerization for Amplification and Detection of a Molecular Recognition Event Yes, download Stephanie Villano
Assay and Analytics CU2296H Non-Invasive, MR-based Diagnosis and Response Monitoring of Malignant Disease Yes, download James Roberts
Assay and Analytics CU2493H Reliable, Non-Radioactive Assay for Prediction and Diagnosis of Type 1A Diabetes and Other Autoimmune Disease Yes, download James Roberts
Assay and Analytics CU3076B Label-free, Un-amplified, Universally Multiplexed Aptasensor via Liquid Crystal-based Detection of Aptamer Binding Yes, download Dipika Singh
Assay and Analytics CU3300B Assessment of pain from functional magnetic resonance imaging activity Yes, download Dipika Singh
Assay and Analytics CU4199B Neurophysiological signature for fibromyalgia Yes, download Dipika Singh
Biomarker(Disease Detection) 2001.058H A Method for Isolation of Prostatic Epithelial Cells from Semen Yes, download Brian Bellesheim
Biomarker(Disease Detection) CU1109H Use of a Novel Autoantigen Epitope as a Diagnostic Tool and Therapeutic Target for Autoimmune Diabetes Yes, download Doreen Molk
Biomarker(Disease Detection) CU1252H Early Detection of Hemangiosarcoma in Dogs and Angiosarcomas in Humans Yes, download James Roberts
Biomarker(Disease Detection) CU1629H Biomarkers for Babesia No, contact TTO Rick Silva
Biomarker(Disease Detection) CU1996H Expression of Novel Cancer Cell Surface Markers in Human Cancer Cells as Biomarkers for Immuno-Escape and Cancer Metastasis Yes, download David Poticha
Biomarker(Disease Detection) CU2038H Application of Pancreatic Beta Cell Surface Protein as a Biomarker and Therapeutic Target or Vector No, contact TTO Paul Tabor
Biomarker(Disease Detection) CU2439H Antibody reactivities associated with COPD as a means of clinical diagnosis and prognosis of lung disease No, contact TTO James Roberts
Biomarker(Disease Detection) CU280H Assay for sulfhydryl amino acids and methods for detecting and distinguishing cobalamin and folic acid deficiency. Combination of CU 280/281 and CU 331 and FD165 No, contact TTO Rick Silva
Biomarker(Drug Response) CU1674H Biomarker for Selection/Modulation of TRAIL and other Cancer Therapies (Six-1 and Eya-2 Diagnostic and Prognostic Biomarkers) No, contact TTO Brian Bellesheim
Biomarker(Drug Response) CU1784H ErbB3 as predictor of response to EGFR Tyrosine kinase inhibitors, upregulated by Histone Deacetylase Inhibitors. No, contact TTO David Poticha
Biomarker(Drug Response) CU2373H Micro RNAs that target key metabolic enzymes and nutrient transporters in breast cancer (Combined with CU2391H -- CU2373H is the record to update and under which patents are filed) Yes, download Brian Bellesheim
Biomarker(Drug Response) CU2988H Cyclophilin-B expression is associated with in vitro radioresistance and clinical outcome after radiotherapy No, contact TTO Kimberly Muller
Biomarker(Drug Response) CU3024H Targeting Treatment for ER-Positive Breast Cancers: A method to predict response to estrogen or androgen pathway inhibitors in breast cancer Yes, download Brian Bellesheim
Biomarker(Drug Response) CU3057H Profile of pro-inflammatory mediators which may predict COPD patient subtypes and responsiveness to therapy No, contact TTO James Roberts
Export to Excel      Back to Main Page